Bioengineered Gum Shows Potential In Cancer Treatment
Food & Wine reported that researchers at the University of Pennsylvania are developing a bioengineered chewing gum from lablab beans to target microbes linked to head and neck cancers, including HPV and specific bacteria. In early lab tests, the gum significantly reduced HPV levels and nearly eliminated harmful bacteria without affecting beneficial oral microbes. Despite promising initial results, further research and clinical trials are needed. The gum has already received FDA clearance for an investigational trial Read more